The study of the safety and efficacy of elemental diet before adjuvant chemotherapy in patients with gastric cancer.

The study of the safety and efficacy of elemental diet before adjuvant chemotherapy in patients with gastric cancer. - Safety and efficacy of elemental diet before adjuvant chemotherapy in patients with gastric cancer.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006499

Enrollment

130

Registered

2011-10-20

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Patients assigned to trial group take elemental diet (ELENTAL) at least more than one pack a day from the 3rd post-operative day for 6 weeks. All the patients including trial group take conventional

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)age. 20<= and 80>= 2)planned to receive adjuvant chemotherapy by TS-1 within 6 weeks after surgery. 3)patients with fully understood the study procedures given informed consent after a sufficient explanation.

Exclusion criteria

Exclusion criteria: 1)patient under some organ failure 2)with other severe diseases 3)patient relevant to contraindication to all use drugs 4)considered inadequate for inclusion in this trial by the physician

Design outcomes

Primary

Measure	Time frame
The rate of initiating adjuvant chemotherapy within 6 weeks after surgery.	—

Secondary

Measure	Time frame
1)total rate of initiating adjuvant chemotherapy after surgery 2)incidence of diarrhea 3)nutritional status 4)safety and tolerability	—

Countries

Japan

Contacts

Public ContactAkinori Takagane

Hakodate Goryoukaku Hospital Department of Surgery

takagane@gobyou.com0138-51-2295

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026